ESOMEPRAZOLE STRONTIUM (R2 Pharma, LLC)


Welcome to the PulseAid listing for the ESOMEPRAZOLE STRONTIUM drug offered from R2 Pharma, LLC. This Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: R2 Pharma, LLC
NON-PROPRIETARY NAME: esomeprazole strontium
SUBSTANCE NAME: ESOMEPRAZOLE STRONTIUM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: CAPSULE, DELAYED RELEASE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2016-09-15
END MARKETING DATE: 0000-00-00


ESOMEPRAZOLE STRONTIUM HUMAN PRESCRIPTION DRUG Details:

Item DescriptionESOMEPRAZOLE STRONTIUM from R2 Pharma, LLC
LABELER NAME: R2 Pharma, LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 20(mg/1)
START MARKETING DATE: 2016-09-15
END MARKETING DATE: 0000-00-00
PRODUCT ID: 70849-200_3d19523d-7cb5-2f2f-e054-00144ff88e88
PRODUCT NDC: 70849-200
APPLICATION NUMBER: NDA202342

Other ESOMEPRAZOLE STRONTIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Amneal Pharmaceuticals of New York, LLCEsomeprazole strontium
Amneal Pharmaceuticals, LLCEsomeprazole strontium
ParaPRO LLCESOMEPRAZOLE STRONTIUM
R2 Pharma, LLCESOMEPRAZOLE STRONTIUM